Copyright © 2018 Claristock. All Right Reserved
Total Mark
70
Above 70 is preferred
Stock Analysis
| Growth Potential | 73 | |
|---|---|---|
| Profitability | 73 | |
| Financial Strength | 86 | |
| Q4 2019 Result | 33 | |
| Q3 2019 Result | 44 | |
| Result 2019 | 59 |
Growth Estimate
| 20 Estimate | 21 Estimate | |
|---|---|---|
| Revenue Growth (%) | 10.4 | 24.6 |
| EPS Growth (%) | -8.5 | 50.6 |
| ROE (%) | 18.1 | 26 |
| P/E (times) | ... | ... |
Market Analysis
| Market Sentiment | 0 | |
|---|---|---|
| Relative Valuation | 50 | |
| Being a Value Stock | 49 | |
| Absolute Valuation | 6 |
For more detailed information about Horizon Therapeutics Plc, please go to Yahoo Finance